VeriMom¿Es polybutylene glycol/mdi copolymer seguro durante el embarazo?
No harmonised reproductive classification (ECHA Annex VI) or CIR/SCCS opinion for 'polybutylene glycol/MDI copolymer' was identified. Regulatory concerns for MDI relate mainly to sensitisation and acute toxicity; polymeric MDI products are generally considered distinct from monomeric MDI with much lower bioavailability. In absence of reproductive/toxicology data or harmonised H360/H361 classifications for this specific polymer, default scoring is 0. Sources consulted: ECHA Annex VI (harmonised CLP), PubChem (MDI hazard profile), ECHA registration dossiers/CosIng (no reproductive classification for polymer).
Related ingredients
Frequently asked questions
- ¿Es polybutylene glycol/mdi copolymer seguro durante el embarazo?
- No harmonised reproductive classification (ECHA Annex VI) or CIR/SCCS opinion for 'polybutylene glycol/MDI copolymer' was identified. Regulatory concerns for MDI relate mainly to sensitisation and acute toxicity; polymeric MDI products are generally considered distinct from monomeric MDI with much lower bioavailability. In absence of reproductive/toxicology data or harmonised H360/H361 classifications for this specific polymer, default scoring is 0. Sources consulted: ECHA Annex VI (harmonised CLP), PubChem (MDI hazard profile), ECHA registration dossiers/CosIng (no reproductive classification for polymer).
- ¿Es polybutylene glycol/mdi copolymer seguro durante la lactancia?
- Same rationale as for pregnancy: no specific reproductive or lactation hazard identified for the polymer. Potential risk would stem from residual monomer (MDI) which is primarily a local irritant/sensitiser; no evidence that the polymer itself transfers into milk or causes systemic reproductive toxicity. No CIR/SCCS or harmonised CLP reproductive flags for the polymer were found.
- ¿Es polybutylene glycol/mdi copolymer seguro para la piel del bebé?
- Hazard and mechanism remain 0 for the polymer (no reproductive/teratogenic evidence). Exposure score increased by +1 for infants because infant skin has higher permeability and surface area:weight, so if any low‑MW residual MDI/oligomers are present they could have measurable absorption. However, the intact high‑MW polymer itself is expected to have negligible dermal absorption. Key concern is residual free MDI rather than the polymer.
- ¿Cómo puntúa VeriMom a polybutylene glycol/mdi copolymer?
- VeriMom puntúa polybutylene glycol/mdi copolymer en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a polybutylene glycol/mdi copolymer en el embarazo?
- Consulta nuestra lista de alternativas seguras a polybutylene glycol/mdi copolymer según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.